nodes	percent_of_prediction	percent_of_DWPC	metapath
Mycophenolate mofetil—UGT2B7—Epirubicin—uterine cancer	0.0739	0.127	CbGbCtD
Mycophenolate mofetil—UGT1A1—Etoposide—uterine cancer	0.0498	0.0855	CbGbCtD
Mycophenolate mofetil—CYP2C8—Medroxyprogesterone Acetate—uterine cancer	0.0492	0.0845	CbGbCtD
Mycophenolate mofetil—ABCG2—Dactinomycin—uterine cancer	0.0485	0.0833	CbGbCtD
Mycophenolate mofetil—ABCC2—Carboplatin—uterine cancer	0.0361	0.0619	CbGbCtD
Mycophenolate mofetil—CYP3A5—Progesterone—uterine cancer	0.0339	0.0582	CbGbCtD
Mycophenolate mofetil—ABCG2—Carboplatin—uterine cancer	0.0326	0.056	CbGbCtD
Mycophenolate mofetil—CYP2C8—Progesterone—uterine cancer	0.0326	0.056	CbGbCtD
Mycophenolate mofetil—ABCC2—Etoposide—uterine cancer	0.0303	0.052	CbGbCtD
Mycophenolate mofetil—ABCG2—Etoposide—uterine cancer	0.0274	0.047	CbGbCtD
Mycophenolate mofetil—ABCB1—Progesterone—uterine cancer	0.0221	0.0379	CbGbCtD
Mycophenolate mofetil—ABCC2—Doxorubicin—uterine cancer	0.0207	0.0355	CbGbCtD
Mycophenolate mofetil—CYP3A4—Medroxyprogesterone Acetate—uterine cancer	0.0199	0.0343	CbGbCtD
Mycophenolate mofetil—ABCG2—Doxorubicin—uterine cancer	0.0187	0.0321	CbGbCtD
Mycophenolate mofetil—ABCB1—Dactinomycin—uterine cancer	0.0175	0.03	CbGbCtD
Mycophenolate mofetil—CYP3A5—Etoposide—uterine cancer	0.0152	0.026	CbGbCtD
Mycophenolate mofetil—CYP2C8—Etoposide—uterine cancer	0.0146	0.025	CbGbCtD
Mycophenolate mofetil—CYP3A4—Progesterone—uterine cancer	0.0132	0.0227	CbGbCtD
Mycophenolate mofetil—ABCB1—Etoposide—uterine cancer	0.00987	0.017	CbGbCtD
Mycophenolate mofetil—ABCB1—Doxorubicin—uterine cancer	0.00673	0.0116	CbGbCtD
Mycophenolate mofetil—IMPDH2—oviduct—uterine cancer	0.00631	0.0727	CbGeAlD
Mycophenolate mofetil—CYP3A4—Etoposide—uterine cancer	0.00591	0.0102	CbGbCtD
Mycophenolate mofetil—CYP3A4—Doxorubicin—uterine cancer	0.00403	0.00693	CbGbCtD
Mycophenolate mofetil—UGT1A7—renal system—uterine cancer	0.00395	0.0455	CbGeAlD
Mycophenolate mofetil—UGT1A10—renal system—uterine cancer	0.0033	0.038	CbGeAlD
Mycophenolate mofetil—UGT1A8—renal system—uterine cancer	0.00261	0.0301	CbGeAlD
Mycophenolate mofetil—IMPDH2—Levonorgestrel—Progesterone—uterine cancer	0.00237	1	CbGdCrCtD
Mycophenolate mofetil—IMPDH2—myometrium—uterine cancer	0.00202	0.0233	CbGeAlD
Mycophenolate mofetil—IMPDH1—myometrium—uterine cancer	0.00201	0.0231	CbGeAlD
Mycophenolate mofetil—CES2—myometrium—uterine cancer	0.00184	0.0211	CbGeAlD
Mycophenolate mofetil—UGT1A9—renal system—uterine cancer	0.00166	0.0191	CbGeAlD
Mycophenolate mofetil—IMPDH2—uterine cervix—uterine cancer	0.00157	0.0181	CbGeAlD
Mycophenolate mofetil—IMPDH1—uterine cervix—uterine cancer	0.00156	0.018	CbGeAlD
Mycophenolate mofetil—IMPDH2—smooth muscle tissue—uterine cancer	0.00153	0.0176	CbGeAlD
Mycophenolate mofetil—IMPDH1—smooth muscle tissue—uterine cancer	0.00152	0.0175	CbGeAlD
Mycophenolate mofetil—IMPDH2—decidua—uterine cancer	0.0015	0.0172	CbGeAlD
Mycophenolate mofetil—IMPDH1—decidua—uterine cancer	0.00149	0.0171	CbGeAlD
Mycophenolate mofetil—IMPDH2—renal system—uterine cancer	0.00147	0.0169	CbGeAlD
Mycophenolate mofetil—IMPDH1—renal system—uterine cancer	0.00146	0.0168	CbGeAlD
Mycophenolate mofetil—CES2—uterine cervix—uterine cancer	0.00143	0.0165	CbGeAlD
Mycophenolate mofetil—IMPDH2—endometrium—uterine cancer	0.00142	0.0164	CbGeAlD
Mycophenolate mofetil—IMPDH1—endometrium—uterine cancer	0.00141	0.0163	CbGeAlD
Mycophenolate mofetil—CES2—smooth muscle tissue—uterine cancer	0.00139	0.016	CbGeAlD
Mycophenolate mofetil—IMPDH2—mammalian vulva—uterine cancer	0.00138	0.0158	CbGeAlD
Mycophenolate mofetil—IMPDH1—mammalian vulva—uterine cancer	0.00137	0.0157	CbGeAlD
Mycophenolate mofetil—CES2—decidua—uterine cancer	0.00136	0.0157	CbGeAlD
Mycophenolate mofetil—CES2—renal system—uterine cancer	0.00134	0.0154	CbGeAlD
Mycophenolate mofetil—UGT2B7—renal system—uterine cancer	0.00134	0.0154	CbGeAlD
Mycophenolate mofetil—IMPDH2—uterus—uterine cancer	0.00131	0.0151	CbGeAlD
Mycophenolate mofetil—IMPDH1—uterus—uterine cancer	0.0013	0.015	CbGeAlD
Mycophenolate mofetil—CES2—endometrium—uterine cancer	0.00129	0.0149	CbGeAlD
Mycophenolate mofetil—CES2—mammalian vulva—uterine cancer	0.00125	0.0144	CbGeAlD
Mycophenolate mofetil—CES2—uterus—uterine cancer	0.00119	0.0137	CbGeAlD
Mycophenolate mofetil—SLCO1B3—vagina—uterine cancer	0.00118	0.0136	CbGeAlD
Mycophenolate mofetil—IMPDH2—female reproductive system—uterine cancer	0.00118	0.0136	CbGeAlD
Mycophenolate mofetil—IMPDH1—female reproductive system—uterine cancer	0.00117	0.0135	CbGeAlD
Mycophenolate mofetil—UGT1A1—renal system—uterine cancer	0.00114	0.0131	CbGeAlD
Mycophenolate mofetil—IMPDH2—female gonad—uterine cancer	0.00107	0.0123	CbGeAlD
Mycophenolate mofetil—CES2—female reproductive system—uterine cancer	0.00107	0.0123	CbGeAlD
Mycophenolate mofetil—UGT2B7—female reproductive system—uterine cancer	0.00107	0.0123	CbGeAlD
Mycophenolate mofetil—IMPDH2—vagina—uterine cancer	0.00107	0.0123	CbGeAlD
Mycophenolate mofetil—IMPDH1—female gonad—uterine cancer	0.00106	0.0123	CbGeAlD
Mycophenolate mofetil—IMPDH1—vagina—uterine cancer	0.00106	0.0122	CbGeAlD
Mycophenolate mofetil—CES2—female gonad—uterine cancer	0.000974	0.0112	CbGeAlD
Mycophenolate mofetil—CES2—vagina—uterine cancer	0.000968	0.0111	CbGeAlD
Mycophenolate mofetil—SLCO1B1—renal system—uterine cancer	0.000946	0.0109	CbGeAlD
Mycophenolate mofetil—CES1—female reproductive system—uterine cancer	0.000881	0.0102	CbGeAlD
Mycophenolate mofetil—CES1—female gonad—uterine cancer	0.000802	0.00924	CbGeAlD
Mycophenolate mofetil—SLCO1B1—female reproductive system—uterine cancer	0.000757	0.00872	CbGeAlD
Mycophenolate mofetil—ABCG2—myometrium—uterine cancer	0.000718	0.00827	CbGeAlD
Mycophenolate mofetil—ABCC2—renal system—uterine cancer	0.000717	0.00826	CbGeAlD
Mycophenolate mofetil—IMPDH2—lymph node—uterine cancer	0.000689	0.00793	CbGeAlD
Mycophenolate mofetil—IMPDH1—lymph node—uterine cancer	0.000685	0.00788	CbGeAlD
Mycophenolate mofetil—CES2—lymph node—uterine cancer	0.000626	0.00721	CbGeAlD
Mycophenolate mofetil—ABCC2—female reproductive system—uterine cancer	0.000574	0.00661	CbGeAlD
Mycophenolate mofetil—ABCG2—uterine cervix—uterine cancer	0.000559	0.00644	CbGeAlD
Mycophenolate mofetil—CYP2C8—renal system—uterine cancer	0.000538	0.00619	CbGeAlD
Mycophenolate mofetil—ABCG2—decidua—uterine cancer	0.000532	0.00613	CbGeAlD
Mycophenolate mofetil—CYP2C8—endometrium—uterine cancer	0.00052	0.00599	CbGeAlD
Mycophenolate mofetil—CYP3A5—uterine cervix—uterine cancer	0.000519	0.00597	CbGeAlD
Mycophenolate mofetil—CES1—lymph node—uterine cancer	0.000516	0.00594	CbGeAlD
Mycophenolate mofetil—ABCG2—endometrium—uterine cancer	0.000505	0.00582	CbGeAlD
Mycophenolate mofetil—ABCG2—mammalian vulva—uterine cancer	0.000489	0.00563	CbGeAlD
Mycophenolate mofetil—CYP3A5—renal system—uterine cancer	0.000485	0.00559	CbGeAlD
Mycophenolate mofetil—ABCG2—uterus—uterine cancer	0.000466	0.00536	CbGeAlD
Mycophenolate mofetil—CYP2C8—female reproductive system—uterine cancer	0.000431	0.00496	CbGeAlD
Mycophenolate mofetil—CYP2C8—vagina—uterine cancer	0.000389	0.00448	CbGeAlD
Mycophenolate mofetil—ABCG2—female gonad—uterine cancer	0.000381	0.00439	CbGeAlD
Mycophenolate mofetil—ABCG2—vagina—uterine cancer	0.000379	0.00436	CbGeAlD
Mycophenolate mofetil—CYP3A4—renal system—uterine cancer	0.000364	0.00419	CbGeAlD
Mycophenolate mofetil—ALB—lymph node—uterine cancer	0.000358	0.00413	CbGeAlD
Mycophenolate mofetil—ABCB1—myometrium—uterine cancer	0.000354	0.00408	CbGeAlD
Mycophenolate mofetil—CYP3A5—female gonad—uterine cancer	0.000354	0.00407	CbGeAlD
Mycophenolate mofetil—CYP3A5—vagina—uterine cancer	0.000351	0.00405	CbGeAlD
Mycophenolate mofetil—ABCC2—lymph node—uterine cancer	0.000336	0.00387	CbGeAlD
Mycophenolate mofetil—CYP3A4—female reproductive system—uterine cancer	0.000292	0.00336	CbGeAlD
Mycophenolate mofetil—ABCB1—epithelium—uterine cancer	0.000278	0.0032	CbGeAlD
Mycophenolate mofetil—ABCB1—uterine cervix—uterine cancer	0.000276	0.00317	CbGeAlD
Mycophenolate mofetil—ABCB1—decidua—uterine cancer	0.000263	0.00302	CbGeAlD
Mycophenolate mofetil—ABCB1—renal system—uterine cancer	0.000258	0.00297	CbGeAlD
Mycophenolate mofetil—ABCB1—endometrium—uterine cancer	0.000249	0.00287	CbGeAlD
Mycophenolate mofetil—ABCG2—lymph node—uterine cancer	0.000245	0.00282	CbGeAlD
Mycophenolate mofetil—ABCB1—mammalian vulva—uterine cancer	0.000241	0.00278	CbGeAlD
Mycophenolate mofetil—ABCB1—uterus—uterine cancer	0.00023	0.00264	CbGeAlD
Mycophenolate mofetil—ABCB1—female reproductive system—uterine cancer	0.000206	0.00238	CbGeAlD
Mycophenolate mofetil—ABCB1—female gonad—uterine cancer	0.000188	0.00216	CbGeAlD
Mycophenolate mofetil—ABCB1—vagina—uterine cancer	0.000187	0.00215	CbGeAlD
Mycophenolate mofetil—ABCB1—lymph node—uterine cancer	0.000121	0.00139	CbGeAlD
Mycophenolate mofetil—Bronchitis—Epirubicin—uterine cancer	8.67e-05	0.00035	CcSEcCtD
Mycophenolate mofetil—Diarrhoea—Dactinomycin—uterine cancer	8.65e-05	0.000349	CcSEcCtD
Mycophenolate mofetil—Pancytopenia—Epirubicin—uterine cancer	8.56e-05	0.000346	CcSEcCtD
Mycophenolate mofetil—Hypotension—Etoposide—uterine cancer	8.55e-05	0.000345	CcSEcCtD
Mycophenolate mofetil—Gastritis—Doxorubicin—uterine cancer	8.54e-05	0.000345	CcSEcCtD
Mycophenolate mofetil—Muscular weakness—Doxorubicin—uterine cancer	8.51e-05	0.000344	CcSEcCtD
Mycophenolate mofetil—Alanine aminotransferase increased—Doxorubicin—uterine cancer	8.51e-05	0.000344	CcSEcCtD
Mycophenolate mofetil—Neutropenia—Epirubicin—uterine cancer	8.43e-05	0.000341	CcSEcCtD
Mycophenolate mofetil—Dysuria—Epirubicin—uterine cancer	8.43e-05	0.000341	CcSEcCtD
Mycophenolate mofetil—Abdominal distension—Doxorubicin—uterine cancer	8.4e-05	0.000339	CcSEcCtD
Mycophenolate mofetil—Asthma—Doxorubicin—uterine cancer	8.34e-05	0.000337	CcSEcCtD
Mycophenolate mofetil—Influenza—Doxorubicin—uterine cancer	8.34e-05	0.000337	CcSEcCtD
Mycophenolate mofetil—Dysphagia—Doxorubicin—uterine cancer	8.34e-05	0.000337	CcSEcCtD
Mycophenolate mofetil—Pollakiuria—Epirubicin—uterine cancer	8.33e-05	0.000336	CcSEcCtD
Mycophenolate mofetil—Paraesthesia—Etoposide—uterine cancer	8.21e-05	0.000332	CcSEcCtD
Mycophenolate mofetil—Weight increased—Epirubicin—uterine cancer	8.21e-05	0.000331	CcSEcCtD
Mycophenolate mofetil—Pancreatitis—Doxorubicin—uterine cancer	8.18e-05	0.00033	CcSEcCtD
Mycophenolate mofetil—Weight decreased—Epirubicin—uterine cancer	8.16e-05	0.000329	CcSEcCtD
Mycophenolate mofetil—Dyspnoea—Etoposide—uterine cancer	8.15e-05	0.000329	CcSEcCtD
Mycophenolate mofetil—Hyperglycaemia—Epirubicin—uterine cancer	8.13e-05	0.000328	CcSEcCtD
Mycophenolate mofetil—Somnolence—Etoposide—uterine cancer	8.13e-05	0.000328	CcSEcCtD
Mycophenolate mofetil—Angina pectoris—Doxorubicin—uterine cancer	8.13e-05	0.000328	CcSEcCtD
Mycophenolate mofetil—Pneumonia—Epirubicin—uterine cancer	8.09e-05	0.000327	CcSEcCtD
Mycophenolate mofetil—Infestation NOS—Epirubicin—uterine cancer	8.04e-05	0.000325	CcSEcCtD
Mycophenolate mofetil—Infestation—Epirubicin—uterine cancer	8.04e-05	0.000325	CcSEcCtD
Mycophenolate mofetil—Vomiting—Dactinomycin—uterine cancer	8.04e-05	0.000325	CcSEcCtD
Mycophenolate mofetil—Bronchitis—Doxorubicin—uterine cancer	8.02e-05	0.000324	CcSEcCtD
Mycophenolate mofetil—Rash—Dactinomycin—uterine cancer	7.97e-05	0.000322	CcSEcCtD
Mycophenolate mofetil—Decreased appetite—Etoposide—uterine cancer	7.95e-05	0.000321	CcSEcCtD
Mycophenolate mofetil—Pancytopenia—Doxorubicin—uterine cancer	7.92e-05	0.00032	CcSEcCtD
Mycophenolate mofetil—Renal failure—Epirubicin—uterine cancer	7.9e-05	0.000319	CcSEcCtD
Mycophenolate mofetil—Gastrointestinal disorder—Etoposide—uterine cancer	7.9e-05	0.000319	CcSEcCtD
Mycophenolate mofetil—Neuropathy peripheral—Epirubicin—uterine cancer	7.88e-05	0.000318	CcSEcCtD
Mycophenolate mofetil—Jaundice—Epirubicin—uterine cancer	7.84e-05	0.000316	CcSEcCtD
Mycophenolate mofetil—Stomatitis—Epirubicin—uterine cancer	7.84e-05	0.000316	CcSEcCtD
Mycophenolate mofetil—Pain—Etoposide—uterine cancer	7.82e-05	0.000316	CcSEcCtD
Mycophenolate mofetil—Constipation—Etoposide—uterine cancer	7.82e-05	0.000316	CcSEcCtD
Mycophenolate mofetil—Urinary tract infection—Epirubicin—uterine cancer	7.81e-05	0.000316	CcSEcCtD
Mycophenolate mofetil—Conjunctivitis—Epirubicin—uterine cancer	7.81e-05	0.000316	CcSEcCtD
Mycophenolate mofetil—Dysuria—Doxorubicin—uterine cancer	7.8e-05	0.000315	CcSEcCtD
Mycophenolate mofetil—Neutropenia—Doxorubicin—uterine cancer	7.8e-05	0.000315	CcSEcCtD
Mycophenolate mofetil—Sweating—Epirubicin—uterine cancer	7.71e-05	0.000311	CcSEcCtD
Mycophenolate mofetil—Pollakiuria—Doxorubicin—uterine cancer	7.71e-05	0.000311	CcSEcCtD
Mycophenolate mofetil—Haematuria—Epirubicin—uterine cancer	7.66e-05	0.00031	CcSEcCtD
Mycophenolate mofetil—Hepatobiliary disease—Epirubicin—uterine cancer	7.6e-05	0.000307	CcSEcCtD
Mycophenolate mofetil—Weight increased—Doxorubicin—uterine cancer	7.59e-05	0.000307	CcSEcCtD
Mycophenolate mofetil—Epistaxis—Epirubicin—uterine cancer	7.58e-05	0.000306	CcSEcCtD
Mycophenolate mofetil—Weight decreased—Doxorubicin—uterine cancer	7.55e-05	0.000305	CcSEcCtD
Mycophenolate mofetil—Sinusitis—Epirubicin—uterine cancer	7.54e-05	0.000305	CcSEcCtD
Mycophenolate mofetil—Feeling abnormal—Etoposide—uterine cancer	7.54e-05	0.000304	CcSEcCtD
Mycophenolate mofetil—Hyperglycaemia—Doxorubicin—uterine cancer	7.53e-05	0.000304	CcSEcCtD
Mycophenolate mofetil—Nausea—Dactinomycin—uterine cancer	7.51e-05	0.000303	CcSEcCtD
Mycophenolate mofetil—Agranulocytosis—Epirubicin—uterine cancer	7.5e-05	0.000303	CcSEcCtD
Mycophenolate mofetil—Pneumonia—Doxorubicin—uterine cancer	7.48e-05	0.000302	CcSEcCtD
Mycophenolate mofetil—Gastrointestinal pain—Etoposide—uterine cancer	7.48e-05	0.000302	CcSEcCtD
Mycophenolate mofetil—Infestation NOS—Doxorubicin—uterine cancer	7.44e-05	0.0003	CcSEcCtD
Mycophenolate mofetil—Infestation—Doxorubicin—uterine cancer	7.44e-05	0.0003	CcSEcCtD
Mycophenolate mofetil—Bradycardia—Epirubicin—uterine cancer	7.35e-05	0.000297	CcSEcCtD
Mycophenolate mofetil—Renal failure—Doxorubicin—uterine cancer	7.31e-05	0.000295	CcSEcCtD
Mycophenolate mofetil—Neuropathy peripheral—Doxorubicin—uterine cancer	7.29e-05	0.000294	CcSEcCtD
Mycophenolate mofetil—Urticaria—Etoposide—uterine cancer	7.27e-05	0.000293	CcSEcCtD
Mycophenolate mofetil—Haemoglobin—Epirubicin—uterine cancer	7.25e-05	0.000293	CcSEcCtD
Mycophenolate mofetil—Jaundice—Doxorubicin—uterine cancer	7.25e-05	0.000293	CcSEcCtD
Mycophenolate mofetil—Stomatitis—Doxorubicin—uterine cancer	7.25e-05	0.000293	CcSEcCtD
Mycophenolate mofetil—Rhinitis—Epirubicin—uterine cancer	7.23e-05	0.000292	CcSEcCtD
Mycophenolate mofetil—Body temperature increased—Etoposide—uterine cancer	7.23e-05	0.000292	CcSEcCtD
Mycophenolate mofetil—Abdominal pain—Etoposide—uterine cancer	7.23e-05	0.000292	CcSEcCtD
Mycophenolate mofetil—Conjunctivitis—Doxorubicin—uterine cancer	7.23e-05	0.000292	CcSEcCtD
Mycophenolate mofetil—Urinary tract infection—Doxorubicin—uterine cancer	7.23e-05	0.000292	CcSEcCtD
Mycophenolate mofetil—Hepatitis—Epirubicin—uterine cancer	7.22e-05	0.000291	CcSEcCtD
Mycophenolate mofetil—Haemorrhage—Epirubicin—uterine cancer	7.22e-05	0.000291	CcSEcCtD
Mycophenolate mofetil—Hypoaesthesia—Epirubicin—uterine cancer	7.18e-05	0.00029	CcSEcCtD
Mycophenolate mofetil—Pharyngitis—Epirubicin—uterine cancer	7.16e-05	0.000289	CcSEcCtD
Mycophenolate mofetil—Sweating—Doxorubicin—uterine cancer	7.13e-05	0.000288	CcSEcCtD
Mycophenolate mofetil—Urinary tract disorder—Epirubicin—uterine cancer	7.13e-05	0.000288	CcSEcCtD
Mycophenolate mofetil—Oedema peripheral—Epirubicin—uterine cancer	7.11e-05	0.000287	CcSEcCtD
Mycophenolate mofetil—Haematuria—Doxorubicin—uterine cancer	7.09e-05	0.000286	CcSEcCtD
Mycophenolate mofetil—Connective tissue disorder—Epirubicin—uterine cancer	7.09e-05	0.000286	CcSEcCtD
Mycophenolate mofetil—Urethral disorder—Epirubicin—uterine cancer	7.07e-05	0.000286	CcSEcCtD
Mycophenolate mofetil—Hepatobiliary disease—Doxorubicin—uterine cancer	7.03e-05	0.000284	CcSEcCtD
Mycophenolate mofetil—Epistaxis—Doxorubicin—uterine cancer	7.02e-05	0.000283	CcSEcCtD
Mycophenolate mofetil—Sinusitis—Doxorubicin—uterine cancer	6.98e-05	0.000282	CcSEcCtD
Mycophenolate mofetil—Visual impairment—Epirubicin—uterine cancer	6.95e-05	0.000281	CcSEcCtD
Mycophenolate mofetil—Agranulocytosis—Doxorubicin—uterine cancer	6.94e-05	0.00028	CcSEcCtD
Mycophenolate mofetil—Bradycardia—Doxorubicin—uterine cancer	6.8e-05	0.000275	CcSEcCtD
Mycophenolate mofetil—Eye disorder—Epirubicin—uterine cancer	6.74e-05	0.000272	CcSEcCtD
Mycophenolate mofetil—Hypersensitivity—Etoposide—uterine cancer	6.74e-05	0.000272	CcSEcCtD
Mycophenolate mofetil—Tinnitus—Epirubicin—uterine cancer	6.73e-05	0.000272	CcSEcCtD
Mycophenolate mofetil—Haemoglobin—Doxorubicin—uterine cancer	6.71e-05	0.000271	CcSEcCtD
Mycophenolate mofetil—Cardiac disorder—Epirubicin—uterine cancer	6.7e-05	0.000271	CcSEcCtD
Mycophenolate mofetil—Rhinitis—Doxorubicin—uterine cancer	6.69e-05	0.00027	CcSEcCtD
Mycophenolate mofetil—Haemorrhage—Doxorubicin—uterine cancer	6.68e-05	0.00027	CcSEcCtD
Mycophenolate mofetil—Hepatitis—Doxorubicin—uterine cancer	6.68e-05	0.00027	CcSEcCtD
Mycophenolate mofetil—Hypoaesthesia—Doxorubicin—uterine cancer	6.64e-05	0.000268	CcSEcCtD
Mycophenolate mofetil—Pharyngitis—Doxorubicin—uterine cancer	6.63e-05	0.000268	CcSEcCtD
Mycophenolate mofetil—Urinary tract disorder—Doxorubicin—uterine cancer	6.59e-05	0.000266	CcSEcCtD
Mycophenolate mofetil—Oedema peripheral—Doxorubicin—uterine cancer	6.58e-05	0.000266	CcSEcCtD
Mycophenolate mofetil—Asthenia—Etoposide—uterine cancer	6.56e-05	0.000265	CcSEcCtD
Mycophenolate mofetil—Connective tissue disorder—Doxorubicin—uterine cancer	6.56e-05	0.000265	CcSEcCtD
Mycophenolate mofetil—Angiopathy—Epirubicin—uterine cancer	6.55e-05	0.000264	CcSEcCtD
Mycophenolate mofetil—Urethral disorder—Doxorubicin—uterine cancer	6.55e-05	0.000264	CcSEcCtD
Mycophenolate mofetil—Mediastinal disorder—Epirubicin—uterine cancer	6.5e-05	0.000263	CcSEcCtD
Mycophenolate mofetil—Chills—Epirubicin—uterine cancer	6.48e-05	0.000262	CcSEcCtD
Mycophenolate mofetil—Pruritus—Etoposide—uterine cancer	6.47e-05	0.000261	CcSEcCtD
Mycophenolate mofetil—Arrhythmia—Epirubicin—uterine cancer	6.45e-05	0.00026	CcSEcCtD
Mycophenolate mofetil—Visual impairment—Doxorubicin—uterine cancer	6.43e-05	0.00026	CcSEcCtD
Mycophenolate mofetil—Alopecia—Epirubicin—uterine cancer	6.38e-05	0.000258	CcSEcCtD
Mycophenolate mofetil—Mental disorder—Epirubicin—uterine cancer	6.32e-05	0.000255	CcSEcCtD
Mycophenolate mofetil—Malnutrition—Epirubicin—uterine cancer	6.28e-05	0.000254	CcSEcCtD
Mycophenolate mofetil—Diarrhoea—Etoposide—uterine cancer	6.26e-05	0.000253	CcSEcCtD
Mycophenolate mofetil—Eye disorder—Doxorubicin—uterine cancer	6.24e-05	0.000252	CcSEcCtD
Mycophenolate mofetil—Tinnitus—Doxorubicin—uterine cancer	6.23e-05	0.000251	CcSEcCtD
Mycophenolate mofetil—Cardiac disorder—Doxorubicin—uterine cancer	6.2e-05	0.00025	CcSEcCtD
Mycophenolate mofetil—Flatulence—Epirubicin—uterine cancer	6.19e-05	0.00025	CcSEcCtD
Mycophenolate mofetil—Tension—Epirubicin—uterine cancer	6.16e-05	0.000249	CcSEcCtD
Mycophenolate mofetil—Dysgeusia—Epirubicin—uterine cancer	6.15e-05	0.000248	CcSEcCtD
Mycophenolate mofetil—Nervousness—Epirubicin—uterine cancer	6.1e-05	0.000246	CcSEcCtD
Mycophenolate mofetil—Back pain—Epirubicin—uterine cancer	6.08e-05	0.000245	CcSEcCtD
Mycophenolate mofetil—Angiopathy—Doxorubicin—uterine cancer	6.06e-05	0.000245	CcSEcCtD
Mycophenolate mofetil—Dizziness—Etoposide—uterine cancer	6.05e-05	0.000244	CcSEcCtD
Mycophenolate mofetil—Muscle spasms—Epirubicin—uterine cancer	6.04e-05	0.000244	CcSEcCtD
Mycophenolate mofetil—Mediastinal disorder—Doxorubicin—uterine cancer	6.02e-05	0.000243	CcSEcCtD
Mycophenolate mofetil—Chills—Doxorubicin—uterine cancer	5.99e-05	0.000242	CcSEcCtD
Mycophenolate mofetil—Arrhythmia—Doxorubicin—uterine cancer	5.96e-05	0.000241	CcSEcCtD
Mycophenolate mofetil—Alopecia—Doxorubicin—uterine cancer	5.9e-05	0.000238	CcSEcCtD
Mycophenolate mofetil—Mental disorder—Doxorubicin—uterine cancer	5.85e-05	0.000236	CcSEcCtD
Mycophenolate mofetil—Ill-defined disorder—Epirubicin—uterine cancer	5.83e-05	0.000235	CcSEcCtD
Mycophenolate mofetil—Vomiting—Etoposide—uterine cancer	5.82e-05	0.000235	CcSEcCtD
Mycophenolate mofetil—Malnutrition—Doxorubicin—uterine cancer	5.81e-05	0.000235	CcSEcCtD
Mycophenolate mofetil—Anaemia—Epirubicin—uterine cancer	5.81e-05	0.000235	CcSEcCtD
Mycophenolate mofetil—Agitation—Epirubicin—uterine cancer	5.77e-05	0.000233	CcSEcCtD
Mycophenolate mofetil—Rash—Etoposide—uterine cancer	5.77e-05	0.000233	CcSEcCtD
Mycophenolate mofetil—Dermatitis—Etoposide—uterine cancer	5.76e-05	0.000233	CcSEcCtD
Mycophenolate mofetil—Headache—Etoposide—uterine cancer	5.73e-05	0.000231	CcSEcCtD
Mycophenolate mofetil—Flatulence—Doxorubicin—uterine cancer	5.73e-05	0.000231	CcSEcCtD
Mycophenolate mofetil—Tension—Doxorubicin—uterine cancer	5.7e-05	0.00023	CcSEcCtD
Mycophenolate mofetil—Dysgeusia—Doxorubicin—uterine cancer	5.69e-05	0.00023	CcSEcCtD
Mycophenolate mofetil—Malaise—Epirubicin—uterine cancer	5.67e-05	0.000229	CcSEcCtD
Mycophenolate mofetil—Nervousness—Doxorubicin—uterine cancer	5.65e-05	0.000228	CcSEcCtD
Mycophenolate mofetil—Vertigo—Epirubicin—uterine cancer	5.64e-05	0.000228	CcSEcCtD
Mycophenolate mofetil—Syncope—Epirubicin—uterine cancer	5.63e-05	0.000228	CcSEcCtD
Mycophenolate mofetil—Leukopenia—Epirubicin—uterine cancer	5.62e-05	0.000227	CcSEcCtD
Mycophenolate mofetil—Back pain—Doxorubicin—uterine cancer	5.62e-05	0.000227	CcSEcCtD
Mycophenolate mofetil—Muscle spasms—Doxorubicin—uterine cancer	5.59e-05	0.000226	CcSEcCtD
Mycophenolate mofetil—Palpitations—Epirubicin—uterine cancer	5.55e-05	0.000224	CcSEcCtD
Mycophenolate mofetil—Loss of consciousness—Epirubicin—uterine cancer	5.52e-05	0.000223	CcSEcCtD
Mycophenolate mofetil—Cough—Epirubicin—uterine cancer	5.48e-05	0.000221	CcSEcCtD
Mycophenolate mofetil—Convulsion—Epirubicin—uterine cancer	5.44e-05	0.00022	CcSEcCtD
Mycophenolate mofetil—Nausea—Etoposide—uterine cancer	5.43e-05	0.000219	CcSEcCtD
Mycophenolate mofetil—Hypertension—Epirubicin—uterine cancer	5.42e-05	0.000219	CcSEcCtD
Mycophenolate mofetil—Ill-defined disorder—Doxorubicin—uterine cancer	5.39e-05	0.000218	CcSEcCtD
Mycophenolate mofetil—Anaemia—Doxorubicin—uterine cancer	5.37e-05	0.000217	CcSEcCtD
Mycophenolate mofetil—Arthralgia—Epirubicin—uterine cancer	5.35e-05	0.000216	CcSEcCtD
Mycophenolate mofetil—Myalgia—Epirubicin—uterine cancer	5.35e-05	0.000216	CcSEcCtD
Mycophenolate mofetil—Chest pain—Epirubicin—uterine cancer	5.35e-05	0.000216	CcSEcCtD
Mycophenolate mofetil—Agitation—Doxorubicin—uterine cancer	5.34e-05	0.000216	CcSEcCtD
Mycophenolate mofetil—Anxiety—Epirubicin—uterine cancer	5.33e-05	0.000215	CcSEcCtD
Mycophenolate mofetil—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—uterine cancer	5.31e-05	0.000215	CcSEcCtD
Mycophenolate mofetil—Discomfort—Epirubicin—uterine cancer	5.28e-05	0.000213	CcSEcCtD
Mycophenolate mofetil—Malaise—Doxorubicin—uterine cancer	5.24e-05	0.000212	CcSEcCtD
Mycophenolate mofetil—Dry mouth—Epirubicin—uterine cancer	5.23e-05	0.000211	CcSEcCtD
Mycophenolate mofetil—Vertigo—Doxorubicin—uterine cancer	5.22e-05	0.000211	CcSEcCtD
Mycophenolate mofetil—Syncope—Doxorubicin—uterine cancer	5.21e-05	0.000211	CcSEcCtD
Mycophenolate mofetil—Leukopenia—Doxorubicin—uterine cancer	5.2e-05	0.00021	CcSEcCtD
Mycophenolate mofetil—Confusional state—Epirubicin—uterine cancer	5.17e-05	0.000209	CcSEcCtD
Mycophenolate mofetil—Palpitations—Doxorubicin—uterine cancer	5.14e-05	0.000207	CcSEcCtD
Mycophenolate mofetil—Anaphylactic shock—Epirubicin—uterine cancer	5.13e-05	0.000207	CcSEcCtD
Mycophenolate mofetil—Oedema—Epirubicin—uterine cancer	5.13e-05	0.000207	CcSEcCtD
Mycophenolate mofetil—Loss of consciousness—Doxorubicin—uterine cancer	5.11e-05	0.000206	CcSEcCtD
Mycophenolate mofetil—Infection—Epirubicin—uterine cancer	5.09e-05	0.000206	CcSEcCtD
Mycophenolate mofetil—Cough—Doxorubicin—uterine cancer	5.07e-05	0.000205	CcSEcCtD
Mycophenolate mofetil—Shock—Epirubicin—uterine cancer	5.04e-05	0.000204	CcSEcCtD
Mycophenolate mofetil—Convulsion—Doxorubicin—uterine cancer	5.04e-05	0.000203	CcSEcCtD
Mycophenolate mofetil—Nervous system disorder—Epirubicin—uterine cancer	5.03e-05	0.000203	CcSEcCtD
Mycophenolate mofetil—Thrombocytopenia—Epirubicin—uterine cancer	5.02e-05	0.000203	CcSEcCtD
Mycophenolate mofetil—Hypertension—Doxorubicin—uterine cancer	5.02e-05	0.000203	CcSEcCtD
Mycophenolate mofetil—Tachycardia—Epirubicin—uterine cancer	5e-05	0.000202	CcSEcCtD
Mycophenolate mofetil—Skin disorder—Epirubicin—uterine cancer	4.98e-05	0.000201	CcSEcCtD
Mycophenolate mofetil—Hyperhidrosis—Epirubicin—uterine cancer	4.96e-05	0.0002	CcSEcCtD
Mycophenolate mofetil—Myalgia—Doxorubicin—uterine cancer	4.95e-05	0.0002	CcSEcCtD
Mycophenolate mofetil—Arthralgia—Doxorubicin—uterine cancer	4.95e-05	0.0002	CcSEcCtD
Mycophenolate mofetil—Chest pain—Doxorubicin—uterine cancer	4.95e-05	0.0002	CcSEcCtD
Mycophenolate mofetil—Anxiety—Doxorubicin—uterine cancer	4.93e-05	0.000199	CcSEcCtD
Mycophenolate mofetil—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—uterine cancer	4.91e-05	0.000198	CcSEcCtD
Mycophenolate mofetil—Discomfort—Doxorubicin—uterine cancer	4.89e-05	0.000197	CcSEcCtD
Mycophenolate mofetil—Anorexia—Epirubicin—uterine cancer	4.89e-05	0.000197	CcSEcCtD
Mycophenolate mofetil—Dry mouth—Doxorubicin—uterine cancer	4.84e-05	0.000195	CcSEcCtD
Mycophenolate mofetil—Hypotension—Epirubicin—uterine cancer	4.79e-05	0.000194	CcSEcCtD
Mycophenolate mofetil—Confusional state—Doxorubicin—uterine cancer	4.78e-05	0.000193	CcSEcCtD
Mycophenolate mofetil—Anaphylactic shock—Doxorubicin—uterine cancer	4.74e-05	0.000192	CcSEcCtD
Mycophenolate mofetil—Oedema—Doxorubicin—uterine cancer	4.74e-05	0.000192	CcSEcCtD
Mycophenolate mofetil—Infection—Doxorubicin—uterine cancer	4.71e-05	0.00019	CcSEcCtD
Mycophenolate mofetil—Musculoskeletal discomfort—Epirubicin—uterine cancer	4.67e-05	0.000189	CcSEcCtD
Mycophenolate mofetil—Shock—Doxorubicin—uterine cancer	4.67e-05	0.000189	CcSEcCtD
Mycophenolate mofetil—Nervous system disorder—Doxorubicin—uterine cancer	4.65e-05	0.000188	CcSEcCtD
Mycophenolate mofetil—Thrombocytopenia—Doxorubicin—uterine cancer	4.64e-05	0.000188	CcSEcCtD
Mycophenolate mofetil—Insomnia—Epirubicin—uterine cancer	4.64e-05	0.000187	CcSEcCtD
Mycophenolate mofetil—Tachycardia—Doxorubicin—uterine cancer	4.63e-05	0.000187	CcSEcCtD
Mycophenolate mofetil—Skin disorder—Doxorubicin—uterine cancer	4.61e-05	0.000186	CcSEcCtD
Mycophenolate mofetil—Paraesthesia—Epirubicin—uterine cancer	4.6e-05	0.000186	CcSEcCtD
Mycophenolate mofetil—Hyperhidrosis—Doxorubicin—uterine cancer	4.59e-05	0.000185	CcSEcCtD
Mycophenolate mofetil—Dyspnoea—Epirubicin—uterine cancer	4.57e-05	0.000185	CcSEcCtD
Mycophenolate mofetil—Somnolence—Epirubicin—uterine cancer	4.56e-05	0.000184	CcSEcCtD
Mycophenolate mofetil—Anorexia—Doxorubicin—uterine cancer	4.52e-05	0.000183	CcSEcCtD
Mycophenolate mofetil—Dyspepsia—Epirubicin—uterine cancer	4.51e-05	0.000182	CcSEcCtD
Mycophenolate mofetil—Decreased appetite—Epirubicin—uterine cancer	4.46e-05	0.00018	CcSEcCtD
Mycophenolate mofetil—Hypotension—Doxorubicin—uterine cancer	4.43e-05	0.000179	CcSEcCtD
Mycophenolate mofetil—Gastrointestinal disorder—Epirubicin—uterine cancer	4.43e-05	0.000179	CcSEcCtD
Mycophenolate mofetil—Pain—Epirubicin—uterine cancer	4.38e-05	0.000177	CcSEcCtD
Mycophenolate mofetil—Constipation—Epirubicin—uterine cancer	4.38e-05	0.000177	CcSEcCtD
Mycophenolate mofetil—Musculoskeletal discomfort—Doxorubicin—uterine cancer	4.32e-05	0.000175	CcSEcCtD
Mycophenolate mofetil—Insomnia—Doxorubicin—uterine cancer	4.29e-05	0.000173	CcSEcCtD
Mycophenolate mofetil—Paraesthesia—Doxorubicin—uterine cancer	4.26e-05	0.000172	CcSEcCtD
Mycophenolate mofetil—Dyspnoea—Doxorubicin—uterine cancer	4.23e-05	0.000171	CcSEcCtD
Mycophenolate mofetil—Feeling abnormal—Epirubicin—uterine cancer	4.22e-05	0.000171	CcSEcCtD
Mycophenolate mofetil—Somnolence—Doxorubicin—uterine cancer	4.22e-05	0.00017	CcSEcCtD
Mycophenolate mofetil—Gastrointestinal pain—Epirubicin—uterine cancer	4.19e-05	0.000169	CcSEcCtD
Mycophenolate mofetil—Dyspepsia—Doxorubicin—uterine cancer	4.18e-05	0.000169	CcSEcCtD
Mycophenolate mofetil—Decreased appetite—Doxorubicin—uterine cancer	4.12e-05	0.000167	CcSEcCtD
Mycophenolate mofetil—UGT1A6—Metabolism—CYP19A1—uterine cancer	4.11e-05	0.000508	CbGpPWpGaD
Mycophenolate mofetil—UGT1A9—Fatty acid, triacylglycerol, and ketone body metabolism—EP300—uterine cancer	4.1e-05	0.000506	CbGpPWpGaD
Mycophenolate mofetil—Gastrointestinal disorder—Doxorubicin—uterine cancer	4.1e-05	0.000165	CcSEcCtD
Mycophenolate mofetil—CYP3A4—Biological oxidations—CYP11A1—uterine cancer	4.09e-05	0.000506	CbGpPWpGaD
Mycophenolate mofetil—UGT1A9—Metabolism of lipids and lipoproteins—CYP19A1—uterine cancer	4.09e-05	0.000506	CbGpPWpGaD
Mycophenolate mofetil—Urticaria—Epirubicin—uterine cancer	4.07e-05	0.000165	CcSEcCtD
Mycophenolate mofetil—Pain—Doxorubicin—uterine cancer	4.06e-05	0.000164	CcSEcCtD
Mycophenolate mofetil—Constipation—Doxorubicin—uterine cancer	4.06e-05	0.000164	CcSEcCtD
Mycophenolate mofetil—ABCB1—Transmembrane transport of small molecules—ABCC9—uterine cancer	4.06e-05	0.000501	CbGpPWpGaD
Mycophenolate mofetil—Abdominal pain—Epirubicin—uterine cancer	4.05e-05	0.000164	CcSEcCtD
Mycophenolate mofetil—Body temperature increased—Epirubicin—uterine cancer	4.05e-05	0.000164	CcSEcCtD
Mycophenolate mofetil—CYP3A4—Metapathway biotransformation—CYP11A1—uterine cancer	4.04e-05	0.000499	CbGpPWpGaD
Mycophenolate mofetil—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN2B—uterine cancer	4.03e-05	0.000498	CbGpPWpGaD
Mycophenolate mofetil—ALB—FOXA2 and FOXA3 transcription factor networks—AKT1—uterine cancer	4e-05	0.000494	CbGpPWpGaD
Mycophenolate mofetil—UGT2B7—Metabolism—POLD1—uterine cancer	4e-05	0.000494	CbGpPWpGaD
Mycophenolate mofetil—ABCB1—HIF-1-alpha transcription factor network—VEGFA—uterine cancer	3.97e-05	0.000491	CbGpPWpGaD
Mycophenolate mofetil—Feeling abnormal—Doxorubicin—uterine cancer	3.91e-05	0.000158	CcSEcCtD
Mycophenolate mofetil—ALB—Platelet degranulation—VEGFA—uterine cancer	3.89e-05	0.00048	CbGpPWpGaD
Mycophenolate mofetil—Gastrointestinal pain—Doxorubicin—uterine cancer	3.88e-05	0.000157	CcSEcCtD
Mycophenolate mofetil—CYP3A4—Metapathway biotransformation—AKR1C3—uterine cancer	3.81e-05	0.000471	CbGpPWpGaD
Mycophenolate mofetil—SLCO1B1—Metabolism—STAR—uterine cancer	3.79e-05	0.000469	CbGpPWpGaD
Mycophenolate mofetil—SLCO1B1—Metabolism—AKR1B1—uterine cancer	3.79e-05	0.000469	CbGpPWpGaD
Mycophenolate mofetil—Hypersensitivity—Epirubicin—uterine cancer	3.78e-05	0.000153	CcSEcCtD
Mycophenolate mofetil—Urticaria—Doxorubicin—uterine cancer	3.77e-05	0.000152	CcSEcCtD
Mycophenolate mofetil—SLCO1B1—Metabolism of lipids and lipoproteins—CYP19A1—uterine cancer	3.75e-05	0.000463	CbGpPWpGaD
Mycophenolate mofetil—Body temperature increased—Doxorubicin—uterine cancer	3.75e-05	0.000151	CcSEcCtD
Mycophenolate mofetil—Abdominal pain—Doxorubicin—uterine cancer	3.75e-05	0.000151	CcSEcCtD
Mycophenolate mofetil—UGT2B7—Metabolism—AKR1C1—uterine cancer	3.74e-05	0.000462	CbGpPWpGaD
Mycophenolate mofetil—ALB—Response to elevated platelet cytosolic Ca2+—VEGFA—uterine cancer	3.7e-05	0.000457	CbGpPWpGaD
Mycophenolate mofetil—SLCO1B3—Metabolism—RRM2—uterine cancer	3.69e-05	0.000456	CbGpPWpGaD
Mycophenolate mofetil—Asthenia—Epirubicin—uterine cancer	3.68e-05	0.000149	CcSEcCtD
Mycophenolate mofetil—Pruritus—Epirubicin—uterine cancer	3.63e-05	0.000147	CcSEcCtD
Mycophenolate mofetil—CYP2C8—Metabolism of lipids and lipoproteins—AKR1C1—uterine cancer	3.59e-05	0.000444	CbGpPWpGaD
Mycophenolate mofetil—SLCO1B3—Metabolism—DCN—uterine cancer	3.59e-05	0.000443	CbGpPWpGaD
Mycophenolate mofetil—ALB—Metabolism of lipids and lipoproteins—AKR1C1—uterine cancer	3.57e-05	0.000441	CbGpPWpGaD
Mycophenolate mofetil—ABCG2—Metabolism—STAR—uterine cancer	3.51e-05	0.000434	CbGpPWpGaD
Mycophenolate mofetil—ABCG2—Metabolism—AKR1B1—uterine cancer	3.51e-05	0.000434	CbGpPWpGaD
Mycophenolate mofetil—Diarrhoea—Epirubicin—uterine cancer	3.51e-05	0.000142	CcSEcCtD
Mycophenolate mofetil—Hypersensitivity—Doxorubicin—uterine cancer	3.5e-05	0.000141	CcSEcCtD
Mycophenolate mofetil—CYP3A5—Metabolism—SRD5A2—uterine cancer	3.48e-05	0.00043	CbGpPWpGaD
Mycophenolate mofetil—CYP3A5—Metabolism—NDUFB11—uterine cancer	3.48e-05	0.00043	CbGpPWpGaD
Mycophenolate mofetil—ABCB1—Allograft Rejection—VEGFA—uterine cancer	3.44e-05	0.000425	CbGpPWpGaD
Mycophenolate mofetil—ALB—Folate Metabolism—TP53—uterine cancer	3.43e-05	0.000423	CbGpPWpGaD
Mycophenolate mofetil—Asthenia—Doxorubicin—uterine cancer	3.4e-05	0.000137	CcSEcCtD
Mycophenolate mofetil—IMPDH2—Metabolism—PTEN—uterine cancer	3.4e-05	0.00042	CbGpPWpGaD
Mycophenolate mofetil—Dizziness—Epirubicin—uterine cancer	3.39e-05	0.000137	CcSEcCtD
Mycophenolate mofetil—SLCO1B3—Metabolism—CYP11A1—uterine cancer	3.38e-05	0.000417	CbGpPWpGaD
Mycophenolate mofetil—Pruritus—Doxorubicin—uterine cancer	3.36e-05	0.000136	CcSEcCtD
Mycophenolate mofetil—UGT2B7—Metabolism—RRM2—uterine cancer	3.33e-05	0.000412	CbGpPWpGaD
Mycophenolate mofetil—Vomiting—Epirubicin—uterine cancer	3.26e-05	0.000132	CcSEcCtD
Mycophenolate mofetil—UGT1A1—Metabolism—POLD1—uterine cancer	3.25e-05	0.000401	CbGpPWpGaD
Mycophenolate mofetil—UGT1A9—Metabolism—POLD1—uterine cancer	3.25e-05	0.000401	CbGpPWpGaD
Mycophenolate mofetil—Diarrhoea—Doxorubicin—uterine cancer	3.25e-05	0.000131	CcSEcCtD
Mycophenolate mofetil—IMPDH2—Metabolism—EP300—uterine cancer	3.24e-05	0.0004	CbGpPWpGaD
Mycophenolate mofetil—UGT2B7—Metabolism—DCN—uterine cancer	3.24e-05	0.0004	CbGpPWpGaD
Mycophenolate mofetil—Rash—Epirubicin—uterine cancer	3.23e-05	0.000131	CcSEcCtD
Mycophenolate mofetil—Dermatitis—Epirubicin—uterine cancer	3.23e-05	0.00013	CcSEcCtD
Mycophenolate mofetil—Headache—Epirubicin—uterine cancer	3.21e-05	0.00013	CcSEcCtD
Mycophenolate mofetil—SLCO1B3—Metabolism—AKR1C3—uterine cancer	3.19e-05	0.000394	CbGpPWpGaD
Mycophenolate mofetil—Dizziness—Doxorubicin—uterine cancer	3.14e-05	0.000127	CcSEcCtD
Mycophenolate mofetil—UGT1A6—Metabolism—MTHFR—uterine cancer	3.09e-05	0.000382	CbGpPWpGaD
Mycophenolate mofetil—UGT2B7—Metabolism—CYP11A1—uterine cancer	3.05e-05	0.000377	CbGpPWpGaD
Mycophenolate mofetil—Nausea—Epirubicin—uterine cancer	3.05e-05	0.000123	CcSEcCtD
Mycophenolate mofetil—UGT1A1—Metabolism—AKR1C1—uterine cancer	3.04e-05	0.000375	CbGpPWpGaD
Mycophenolate mofetil—UGT1A9—Metabolism—AKR1C1—uterine cancer	3.04e-05	0.000375	CbGpPWpGaD
Mycophenolate mofetil—UGT1A7—Metabolism—PTEN—uterine cancer	3.03e-05	0.000374	CbGpPWpGaD
Mycophenolate mofetil—Vomiting—Doxorubicin—uterine cancer	3.02e-05	0.000122	CcSEcCtD
Mycophenolate mofetil—CYP2C8—Metabolism—NDUFB11—uterine cancer	3.02e-05	0.000373	CbGpPWpGaD
Mycophenolate mofetil—CYP2C8—Metabolism—SRD5A2—uterine cancer	3.02e-05	0.000373	CbGpPWpGaD
Mycophenolate mofetil—CYP3A4—Biological oxidations—CYP19A1—uterine cancer	3.01e-05	0.000372	CbGpPWpGaD
Mycophenolate mofetil—ALB—Hemostasis—IRF1—uterine cancer	3.01e-05	0.000371	CbGpPWpGaD
Mycophenolate mofetil—ABCB1—Integrated Pancreatic Cancer Pathway—ESR1—uterine cancer	3e-05	0.000371	CbGpPWpGaD
Mycophenolate mofetil—ALB—Metabolism—NDUFB11—uterine cancer	3e-05	0.00037	CbGpPWpGaD
Mycophenolate mofetil—ALB—Metabolism—SRD5A2—uterine cancer	3e-05	0.00037	CbGpPWpGaD
Mycophenolate mofetil—Rash—Doxorubicin—uterine cancer	2.99e-05	0.000121	CcSEcCtD
Mycophenolate mofetil—Dermatitis—Doxorubicin—uterine cancer	2.99e-05	0.000121	CcSEcCtD
Mycophenolate mofetil—SLCO1B1—Metabolism—POLD1—uterine cancer	2.98e-05	0.000368	CbGpPWpGaD
Mycophenolate mofetil—Headache—Doxorubicin—uterine cancer	2.97e-05	0.00012	CcSEcCtD
Mycophenolate mofetil—CYP3A4—Metapathway biotransformation—CYP19A1—uterine cancer	2.97e-05	0.000367	CbGpPWpGaD
Mycophenolate mofetil—CYP2C8—Metabolism of lipids and lipoproteins—CYP11A1—uterine cancer	2.93e-05	0.000362	CbGpPWpGaD
Mycophenolate mofetil—ALB—Metabolism of lipids and lipoproteins—CYP11A1—uterine cancer	2.91e-05	0.00036	CbGpPWpGaD
Mycophenolate mofetil—UGT1A7—Metabolism—EP300—uterine cancer	2.89e-05	0.000357	CbGpPWpGaD
Mycophenolate mofetil—UGT2B7—Metabolism—AKR1C3—uterine cancer	2.88e-05	0.000356	CbGpPWpGaD
Mycophenolate mofetil—Nausea—Doxorubicin—uterine cancer	2.82e-05	0.000114	CcSEcCtD
Mycophenolate mofetil—SLCO1B1—Metabolism—AKR1C1—uterine cancer	2.79e-05	0.000344	CbGpPWpGaD
Mycophenolate mofetil—IMPDH1—Metabolism—PTEN—uterine cancer	2.77e-05	0.000342	CbGpPWpGaD
Mycophenolate mofetil—CYP2C8—Metabolism of lipids and lipoproteins—AKR1C3—uterine cancer	2.77e-05	0.000342	CbGpPWpGaD
Mycophenolate mofetil—ABCG2—Metabolism—POLD1—uterine cancer	2.76e-05	0.000341	CbGpPWpGaD
Mycophenolate mofetil—ALB—Metabolism of lipids and lipoproteins—AKR1C3—uterine cancer	2.75e-05	0.00034	CbGpPWpGaD
Mycophenolate mofetil—UGT1A1—Metabolism—RRM2—uterine cancer	2.71e-05	0.000335	CbGpPWpGaD
Mycophenolate mofetil—UGT1A9—Metabolism—RRM2—uterine cancer	2.71e-05	0.000335	CbGpPWpGaD
Mycophenolate mofetil—IMPDH1—Metabolism—EP300—uterine cancer	2.64e-05	0.000326	CbGpPWpGaD
Mycophenolate mofetil—UGT1A1—Metabolism—DCN—uterine cancer	2.63e-05	0.000325	CbGpPWpGaD
Mycophenolate mofetil—UGT1A9—Metabolism—DCN—uterine cancer	2.63e-05	0.000325	CbGpPWpGaD
Mycophenolate mofetil—ABCB1—Metabolism—SRD5A2—uterine cancer	2.63e-05	0.000325	CbGpPWpGaD
Mycophenolate mofetil—ABCB1—Metabolism—NDUFB11—uterine cancer	2.63e-05	0.000325	CbGpPWpGaD
Mycophenolate mofetil—ABCG2—Metabolism—AKR1C1—uterine cancer	2.58e-05	0.000319	CbGpPWpGaD
Mycophenolate mofetil—ABCB1—HIF-1-alpha transcription factor network—AKT1—uterine cancer	2.53e-05	0.000313	CbGpPWpGaD
Mycophenolate mofetil—CYP3A5—Metabolism—AKR1B1—uterine cancer	2.52e-05	0.000311	CbGpPWpGaD
Mycophenolate mofetil—CYP3A5—Metabolism—STAR—uterine cancer	2.52e-05	0.000311	CbGpPWpGaD
Mycophenolate mofetil—SLCO1B3—Metabolism—STK11—uterine cancer	2.49e-05	0.000307	CbGpPWpGaD
Mycophenolate mofetil—SLCO1B3—Metabolism—CYP19A1—uterine cancer	2.49e-05	0.000307	CbGpPWpGaD
Mycophenolate mofetil—SLCO1B1—Metabolism—RRM2—uterine cancer	2.48e-05	0.000307	CbGpPWpGaD
Mycophenolate mofetil—UGT1A1—Metabolism—CYP11A1—uterine cancer	2.48e-05	0.000306	CbGpPWpGaD
Mycophenolate mofetil—UGT1A9—Metabolism—CYP11A1—uterine cancer	2.48e-05	0.000306	CbGpPWpGaD
Mycophenolate mofetil—SLCO1B1—Metabolism—DCN—uterine cancer	2.41e-05	0.000298	CbGpPWpGaD
Mycophenolate mofetil—IMPDH2—Metabolism—PIK3CA—uterine cancer	2.4e-05	0.000296	CbGpPWpGaD
Mycophenolate mofetil—UGT1A8—Metabolism—PTEN—uterine cancer	2.36e-05	0.000291	CbGpPWpGaD
Mycophenolate mofetil—UGT1A1—Metabolism—AKR1C3—uterine cancer	2.34e-05	0.000289	CbGpPWpGaD
Mycophenolate mofetil—UGT1A9—Metabolism—AKR1C3—uterine cancer	2.34e-05	0.000289	CbGpPWpGaD
Mycophenolate mofetil—SLCO1B3—Metabolism of lipids and lipoproteins—PTEN—uterine cancer	2.33e-05	0.000288	CbGpPWpGaD
Mycophenolate mofetil—ABCG2—Metabolism—RRM2—uterine cancer	2.3e-05	0.000284	CbGpPWpGaD
Mycophenolate mofetil—SLCO1B1—Metabolism—CYP11A1—uterine cancer	2.27e-05	0.00028	CbGpPWpGaD
Mycophenolate mofetil—UGT1A8—Metabolism—EP300—uterine cancer	2.25e-05	0.000277	CbGpPWpGaD
Mycophenolate mofetil—UGT2B7—Metabolism—CYP19A1—uterine cancer	2.24e-05	0.000277	CbGpPWpGaD
Mycophenolate mofetil—UGT2B7—Metabolism—STK11—uterine cancer	2.24e-05	0.000277	CbGpPWpGaD
Mycophenolate mofetil—ABCG2—Metabolism—DCN—uterine cancer	2.23e-05	0.000276	CbGpPWpGaD
Mycophenolate mofetil—SLCO1B3—Metabolism of lipids and lipoproteins—EP300—uterine cancer	2.23e-05	0.000275	CbGpPWpGaD
Mycophenolate mofetil—ABCB1—Integrated Pancreatic Cancer Pathway—ERBB2—uterine cancer	2.2e-05	0.000272	CbGpPWpGaD
Mycophenolate mofetil—CYP2C8—Metabolism—STAR—uterine cancer	2.18e-05	0.000269	CbGpPWpGaD
Mycophenolate mofetil—CYP2C8—Metabolism—AKR1B1—uterine cancer	2.18e-05	0.000269	CbGpPWpGaD
Mycophenolate mofetil—ALB—Metabolism—AKR1B1—uterine cancer	2.17e-05	0.000268	CbGpPWpGaD
Mycophenolate mofetil—ALB—Metabolism—STAR—uterine cancer	2.17e-05	0.000268	CbGpPWpGaD
Mycophenolate mofetil—CYP2C8—Metabolism of lipids and lipoproteins—CYP19A1—uterine cancer	2.16e-05	0.000266	CbGpPWpGaD
Mycophenolate mofetil—SLCO1B1—Metabolism—AKR1C3—uterine cancer	2.14e-05	0.000265	CbGpPWpGaD
Mycophenolate mofetil—ALB—Metabolism of lipids and lipoproteins—CYP19A1—uterine cancer	2.14e-05	0.000265	CbGpPWpGaD
Mycophenolate mofetil—UGT1A7—Metabolism—PIK3CA—uterine cancer	2.14e-05	0.000264	CbGpPWpGaD
Mycophenolate mofetil—ABCG2—Metabolism—CYP11A1—uterine cancer	2.1e-05	0.00026	CbGpPWpGaD
Mycophenolate mofetil—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN1B—uterine cancer	2.04e-05	0.000252	CbGpPWpGaD
Mycophenolate mofetil—ABCG2—Metabolism—AKR1C3—uterine cancer	1.99e-05	0.000245	CbGpPWpGaD
Mycophenolate mofetil—CYP3A5—Metabolism—POLD1—uterine cancer	1.98e-05	0.000244	CbGpPWpGaD
Mycophenolate mofetil—IMPDH2—Metabolism—AKT1—uterine cancer	1.96e-05	0.000242	CbGpPWpGaD
Mycophenolate mofetil—IMPDH1—Metabolism—PIK3CA—uterine cancer	1.95e-05	0.000241	CbGpPWpGaD
Mycophenolate mofetil—ABCB1—Integrated Pancreatic Cancer Pathway—CTNNB1—uterine cancer	1.93e-05	0.000238	CbGpPWpGaD
Mycophenolate mofetil—ABCB1—Metabolism—STAR—uterine cancer	1.9e-05	0.000235	CbGpPWpGaD
Mycophenolate mofetil—ABCB1—Metabolism—AKR1B1—uterine cancer	1.9e-05	0.000235	CbGpPWpGaD
Mycophenolate mofetil—ABCB1—Integrated Pancreatic Cancer Pathway—PTEN—uterine cancer	1.88e-05	0.000232	CbGpPWpGaD
Mycophenolate mofetil—SLCO1B3—Metabolism—MTHFR—uterine cancer	1.87e-05	0.000231	CbGpPWpGaD
Mycophenolate mofetil—CYP3A5—Metabolism—AKR1C1—uterine cancer	1.85e-05	0.000228	CbGpPWpGaD
Mycophenolate mofetil—UGT1A1—Metabolism—STK11—uterine cancer	1.82e-05	0.000225	CbGpPWpGaD
Mycophenolate mofetil—UGT1A1—Metabolism—CYP19A1—uterine cancer	1.82e-05	0.000225	CbGpPWpGaD
Mycophenolate mofetil—UGT1A9—Metabolism—STK11—uterine cancer	1.82e-05	0.000225	CbGpPWpGaD
Mycophenolate mofetil—UGT1A9—Metabolism—CYP19A1—uterine cancer	1.82e-05	0.000225	CbGpPWpGaD
Mycophenolate mofetil—ABCB1—Integrated Pancreatic Cancer Pathway—EP300—uterine cancer	1.79e-05	0.000221	CbGpPWpGaD
Mycophenolate mofetil—UGT1A7—Metabolism—AKT1—uterine cancer	1.75e-05	0.000216	CbGpPWpGaD
Mycophenolate mofetil—ALB—Platelet activation, signaling and aggregation—VEGFA—uterine cancer	1.72e-05	0.000213	CbGpPWpGaD
Mycophenolate mofetil—UGT1A6—Metabolism—PTEN—uterine cancer	1.72e-05	0.000212	CbGpPWpGaD
Mycophenolate mofetil—UGT1A9—Metabolism of lipids and lipoproteins—PTEN—uterine cancer	1.71e-05	0.000211	CbGpPWpGaD
Mycophenolate mofetil—CYP2C8—Metabolism—POLD1—uterine cancer	1.71e-05	0.000211	CbGpPWpGaD
Mycophenolate mofetil—ALB—Metabolism—POLD1—uterine cancer	1.7e-05	0.00021	CbGpPWpGaD
Mycophenolate mofetil—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—uterine cancer	1.7e-05	0.00021	CbGpPWpGaD
Mycophenolate mofetil—UGT2B7—Metabolism—MTHFR—uterine cancer	1.69e-05	0.000208	CbGpPWpGaD
Mycophenolate mofetil—SLCO1B1—Metabolism—STK11—uterine cancer	1.67e-05	0.000206	CbGpPWpGaD
Mycophenolate mofetil—SLCO1B1—Metabolism—CYP19A1—uterine cancer	1.67e-05	0.000206	CbGpPWpGaD
Mycophenolate mofetil—UGT1A8—Metabolism—PIK3CA—uterine cancer	1.66e-05	0.000205	CbGpPWpGaD
Mycophenolate mofetil—CYP3A5—Metabolism—RRM2—uterine cancer	1.65e-05	0.000203	CbGpPWpGaD
Mycophenolate mofetil—SLCO1B3—Metabolism of lipids and lipoproteins—PIK3CA—uterine cancer	1.65e-05	0.000203	CbGpPWpGaD
Mycophenolate mofetil—UGT1A6—Metabolism—EP300—uterine cancer	1.64e-05	0.000202	CbGpPWpGaD
Mycophenolate mofetil—UGT1A9—Metabolism of lipids and lipoproteins—EP300—uterine cancer	1.63e-05	0.000202	CbGpPWpGaD
Mycophenolate mofetil—CYP3A4—Metabolism—SRD5A2—uterine cancer	1.62e-05	0.0002	CbGpPWpGaD
Mycophenolate mofetil—CYP3A4—Metabolism—NDUFB11—uterine cancer	1.62e-05	0.0002	CbGpPWpGaD
Mycophenolate mofetil—CYP2C8—Metabolism—AKR1C1—uterine cancer	1.6e-05	0.000198	CbGpPWpGaD
Mycophenolate mofetil—CYP3A5—Metabolism—DCN—uterine cancer	1.6e-05	0.000197	CbGpPWpGaD
Mycophenolate mofetil—IMPDH1—Metabolism—AKT1—uterine cancer	1.6e-05	0.000197	CbGpPWpGaD
Mycophenolate mofetil—ALB—Metabolism—AKR1C1—uterine cancer	1.59e-05	0.000197	CbGpPWpGaD
Mycophenolate mofetil—SLCO1B1—Metabolism of lipids and lipoproteins—PTEN—uterine cancer	1.57e-05	0.000194	CbGpPWpGaD
Mycophenolate mofetil—ABCG2—Metabolism—CYP19A1—uterine cancer	1.55e-05	0.000191	CbGpPWpGaD
Mycophenolate mofetil—ABCG2—Metabolism—STK11—uterine cancer	1.55e-05	0.000191	CbGpPWpGaD
Mycophenolate mofetil—CYP3A5—Metabolism—CYP11A1—uterine cancer	1.51e-05	0.000186	CbGpPWpGaD
Mycophenolate mofetil—SLCO1B1—Metabolism of lipids and lipoproteins—EP300—uterine cancer	1.5e-05	0.000185	CbGpPWpGaD
Mycophenolate mofetil—ABCB1—Metabolism—POLD1—uterine cancer	1.49e-05	0.000184	CbGpPWpGaD
Mycophenolate mofetil—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—uterine cancer	1.44e-05	0.000178	CbGpPWpGaD
Mycophenolate mofetil—CYP2C8—Metabolism—RRM2—uterine cancer	1.43e-05	0.000176	CbGpPWpGaD
Mycophenolate mofetil—CYP3A5—Metabolism—AKR1C3—uterine cancer	1.42e-05	0.000176	CbGpPWpGaD
Mycophenolate mofetil—ALB—Metabolism—RRM2—uterine cancer	1.42e-05	0.000175	CbGpPWpGaD
Mycophenolate mofetil—ABCB1—Metabolism—AKR1C1—uterine cancer	1.39e-05	0.000172	CbGpPWpGaD
Mycophenolate mofetil—CYP2C8—Metabolism—DCN—uterine cancer	1.38e-05	0.000171	CbGpPWpGaD
Mycophenolate mofetil—ALB—Metabolism—DCN—uterine cancer	1.38e-05	0.00017	CbGpPWpGaD
Mycophenolate mofetil—UGT1A1—Metabolism—MTHFR—uterine cancer	1.37e-05	0.000169	CbGpPWpGaD
Mycophenolate mofetil—UGT1A9—Metabolism—MTHFR—uterine cancer	1.37e-05	0.000169	CbGpPWpGaD
Mycophenolate mofetil—UGT1A8—Metabolism—AKT1—uterine cancer	1.36e-05	0.000168	CbGpPWpGaD
Mycophenolate mofetil—ALB—Platelet activation, signaling and aggregation—PIK3CA—uterine cancer	1.35e-05	0.000166	CbGpPWpGaD
Mycophenolate mofetil—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—uterine cancer	1.33e-05	0.000164	CbGpPWpGaD
Mycophenolate mofetil—CYP2C8—Metabolism—CYP11A1—uterine cancer	1.3e-05	0.000161	CbGpPWpGaD
Mycophenolate mofetil—ALB—Metabolism—CYP11A1—uterine cancer	1.3e-05	0.00016	CbGpPWpGaD
Mycophenolate mofetil—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—uterine cancer	1.28e-05	0.000158	CbGpPWpGaD
Mycophenolate mofetil—SLCO1B1—Metabolism—MTHFR—uterine cancer	1.26e-05	0.000155	CbGpPWpGaD
Mycophenolate mofetil—ABCB1—Metabolism—RRM2—uterine cancer	1.24e-05	0.000153	CbGpPWpGaD
Mycophenolate mofetil—CYP2C8—Metabolism—AKR1C3—uterine cancer	1.23e-05	0.000152	CbGpPWpGaD
Mycophenolate mofetil—ALB—Metabolism—AKR1C3—uterine cancer	1.23e-05	0.000151	CbGpPWpGaD
Mycophenolate mofetil—UGT1A6—Metabolism—PIK3CA—uterine cancer	1.21e-05	0.00015	CbGpPWpGaD
Mycophenolate mofetil—UGT1A9—Metabolism of lipids and lipoproteins—PIK3CA—uterine cancer	1.21e-05	0.000149	CbGpPWpGaD
Mycophenolate mofetil—ABCB1—Metabolism—DCN—uterine cancer	1.21e-05	0.000149	CbGpPWpGaD
Mycophenolate mofetil—CYP3A4—Metabolism—STAR—uterine cancer	1.17e-05	0.000145	CbGpPWpGaD
Mycophenolate mofetil—CYP3A4—Metabolism—AKR1B1—uterine cancer	1.17e-05	0.000145	CbGpPWpGaD
Mycophenolate mofetil—ABCG2—Metabolism—MTHFR—uterine cancer	1.16e-05	0.000144	CbGpPWpGaD
Mycophenolate mofetil—ABCB1—Metabolism—CYP11A1—uterine cancer	1.14e-05	0.00014	CbGpPWpGaD
Mycophenolate mofetil—CYP3A5—Metabolism—STK11—uterine cancer	1.11e-05	0.000137	CbGpPWpGaD
Mycophenolate mofetil—CYP3A5—Metabolism—CYP19A1—uterine cancer	1.11e-05	0.000137	CbGpPWpGaD
Mycophenolate mofetil—SLCO1B1—Metabolism of lipids and lipoproteins—PIK3CA—uterine cancer	1.11e-05	0.000137	CbGpPWpGaD
Mycophenolate mofetil—ALB—Platelet activation, signaling and aggregation—AKT1—uterine cancer	1.1e-05	0.000136	CbGpPWpGaD
Mycophenolate mofetil—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—uterine cancer	1.08e-05	0.000134	CbGpPWpGaD
Mycophenolate mofetil—ABCB1—Metabolism—AKR1C3—uterine cancer	1.07e-05	0.000133	CbGpPWpGaD
Mycophenolate mofetil—SLCO1B3—Metabolism—PTEN—uterine cancer	1.04e-05	0.000128	CbGpPWpGaD
Mycophenolate mofetil—SLCO1B3—Metabolism—EP300—uterine cancer	9.91e-06	0.000122	CbGpPWpGaD
Mycophenolate mofetil—UGT1A6—Metabolism—AKT1—uterine cancer	9.9e-06	0.000122	CbGpPWpGaD
Mycophenolate mofetil—CYP2C8—Metabolism—STK11—uterine cancer	9.6e-06	0.000119	CbGpPWpGaD
Mycophenolate mofetil—CYP2C8—Metabolism—CYP19A1—uterine cancer	9.6e-06	0.000119	CbGpPWpGaD
Mycophenolate mofetil—ALB—Metabolism—STK11—uterine cancer	9.54e-06	0.000118	CbGpPWpGaD
Mycophenolate mofetil—ALB—Metabolism—CYP19A1—uterine cancer	9.54e-06	0.000118	CbGpPWpGaD
Mycophenolate mofetil—ALB—Hemostasis—EP300—uterine cancer	9.38e-06	0.000116	CbGpPWpGaD
Mycophenolate mofetil—UGT2B7—Metabolism—PTEN—uterine cancer	9.38e-06	0.000116	CbGpPWpGaD
Mycophenolate mofetil—CYP3A4—Metabolism—POLD1—uterine cancer	9.18e-06	0.000113	CbGpPWpGaD
Mycophenolate mofetil—CYP2C8—Metabolism of lipids and lipoproteins—PTEN—uterine cancer	9.01e-06	0.000111	CbGpPWpGaD
Mycophenolate mofetil—ALB—Metabolism of lipids and lipoproteins—PTEN—uterine cancer	8.96e-06	0.000111	CbGpPWpGaD
Mycophenolate mofetil—UGT2B7—Metabolism—EP300—uterine cancer	8.94e-06	0.00011	CbGpPWpGaD
Mycophenolate mofetil—ALB—Hemostasis—VEGFA—uterine cancer	8.89e-06	0.00011	CbGpPWpGaD
Mycophenolate mofetil—ALB—Hemostasis—NRAS—uterine cancer	8.78e-06	0.000108	CbGpPWpGaD
Mycophenolate mofetil—CYP2C8—Metabolism of lipids and lipoproteins—EP300—uterine cancer	8.59e-06	0.000106	CbGpPWpGaD
Mycophenolate mofetil—CYP3A4—Metabolism—AKR1C1—uterine cancer	8.59e-06	0.000106	CbGpPWpGaD
Mycophenolate mofetil—ALB—Metabolism of lipids and lipoproteins—EP300—uterine cancer	8.54e-06	0.000106	CbGpPWpGaD
Mycophenolate mofetil—ABCB1—Metabolism—CYP19A1—uterine cancer	8.36e-06	0.000103	CbGpPWpGaD
Mycophenolate mofetil—ABCB1—Metabolism—STK11—uterine cancer	8.36e-06	0.000103	CbGpPWpGaD
Mycophenolate mofetil—CYP3A5—Metabolism—MTHFR—uterine cancer	8.33e-06	0.000103	CbGpPWpGaD
Mycophenolate mofetil—CYP3A4—Metabolism—RRM2—uterine cancer	7.66e-06	9.46e-05	CbGpPWpGaD
Mycophenolate mofetil—UGT1A1—Metabolism—PTEN—uterine cancer	7.62e-06	9.41e-05	CbGpPWpGaD
Mycophenolate mofetil—UGT1A9—Metabolism—PTEN—uterine cancer	7.62e-06	9.41e-05	CbGpPWpGaD
Mycophenolate mofetil—ALB—Hemostasis—KRAS—uterine cancer	7.56e-06	9.33e-05	CbGpPWpGaD
Mycophenolate mofetil—CYP3A4—Metabolism—DCN—uterine cancer	7.43e-06	9.18e-05	CbGpPWpGaD
Mycophenolate mofetil—SLCO1B3—Metabolism—PIK3CA—uterine cancer	7.33e-06	9.06e-05	CbGpPWpGaD
Mycophenolate mofetil—UGT1A1—Metabolism—EP300—uterine cancer	7.27e-06	8.98e-05	CbGpPWpGaD
Mycophenolate mofetil—UGT1A9—Metabolism—EP300—uterine cancer	7.27e-06	8.98e-05	CbGpPWpGaD
Mycophenolate mofetil—CYP2C8—Metabolism—MTHFR—uterine cancer	7.21e-06	8.91e-05	CbGpPWpGaD
Mycophenolate mofetil—ALB—Metabolism—MTHFR—uterine cancer	7.17e-06	8.86e-05	CbGpPWpGaD
Mycophenolate mofetil—CYP3A4—Metabolism—CYP11A1—uterine cancer	7e-06	8.65e-05	CbGpPWpGaD
Mycophenolate mofetil—SLCO1B1—Metabolism—PTEN—uterine cancer	6.98e-06	8.63e-05	CbGpPWpGaD
Mycophenolate mofetil—ALB—Hemostasis—PIK3CA—uterine cancer	6.94e-06	8.57e-05	CbGpPWpGaD
Mycophenolate mofetil—ALB—Hemostasis—TP53—uterine cancer	6.72e-06	8.3e-05	CbGpPWpGaD
Mycophenolate mofetil—SLCO1B1—Metabolism—EP300—uterine cancer	6.66e-06	8.23e-05	CbGpPWpGaD
Mycophenolate mofetil—UGT2B7—Metabolism—PIK3CA—uterine cancer	6.62e-06	8.17e-05	CbGpPWpGaD
Mycophenolate mofetil—CYP3A4—Metabolism—AKR1C3—uterine cancer	6.61e-06	8.17e-05	CbGpPWpGaD
Mycophenolate mofetil—ABCG2—Metabolism—PTEN—uterine cancer	6.47e-06	7.99e-05	CbGpPWpGaD
Mycophenolate mofetil—ALB—Hemostasis—HRAS—uterine cancer	6.42e-06	7.93e-05	CbGpPWpGaD
Mycophenolate mofetil—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—uterine cancer	6.36e-06	7.85e-05	CbGpPWpGaD
Mycophenolate mofetil—ALB—Metabolism of lipids and lipoproteins—PIK3CA—uterine cancer	6.32e-06	7.81e-05	CbGpPWpGaD
Mycophenolate mofetil—ABCB1—Metabolism—MTHFR—uterine cancer	6.28e-06	7.76e-05	CbGpPWpGaD
Mycophenolate mofetil—ABCG2—Metabolism—EP300—uterine cancer	6.17e-06	7.62e-05	CbGpPWpGaD
Mycophenolate mofetil—SLCO1B3—Metabolism—AKT1—uterine cancer	5.99e-06	7.4e-05	CbGpPWpGaD
Mycophenolate mofetil—ALB—Hemostasis—AKT1—uterine cancer	5.67e-06	7e-05	CbGpPWpGaD
Mycophenolate mofetil—UGT2B7—Metabolism—AKT1—uterine cancer	5.4e-06	6.68e-05	CbGpPWpGaD
Mycophenolate mofetil—UGT1A1—Metabolism—PIK3CA—uterine cancer	5.38e-06	6.64e-05	CbGpPWpGaD
Mycophenolate mofetil—UGT1A9—Metabolism—PIK3CA—uterine cancer	5.38e-06	6.64e-05	CbGpPWpGaD
Mycophenolate mofetil—CYP3A4—Metabolism—STK11—uterine cancer	5.15e-06	6.36e-05	CbGpPWpGaD
Mycophenolate mofetil—CYP3A4—Metabolism—CYP19A1—uterine cancer	5.15e-06	6.36e-05	CbGpPWpGaD
Mycophenolate mofetil—SLCO1B1—Metabolism—PIK3CA—uterine cancer	4.93e-06	6.08e-05	CbGpPWpGaD
Mycophenolate mofetil—CYP3A5—Metabolism—PTEN—uterine cancer	4.63e-06	5.72e-05	CbGpPWpGaD
Mycophenolate mofetil—ABCG2—Metabolism—PIK3CA—uterine cancer	4.56e-06	5.63e-05	CbGpPWpGaD
Mycophenolate mofetil—CYP3A5—Metabolism—EP300—uterine cancer	4.42e-06	5.46e-05	CbGpPWpGaD
Mycophenolate mofetil—UGT1A1—Metabolism—AKT1—uterine cancer	4.39e-06	5.42e-05	CbGpPWpGaD
Mycophenolate mofetil—UGT1A9—Metabolism—AKT1—uterine cancer	4.39e-06	5.42e-05	CbGpPWpGaD
Mycophenolate mofetil—SLCO1B1—Metabolism—AKT1—uterine cancer	4.02e-06	4.97e-05	CbGpPWpGaD
Mycophenolate mofetil—CYP2C8—Metabolism—PTEN—uterine cancer	4.01e-06	4.96e-05	CbGpPWpGaD
Mycophenolate mofetil—ALB—Metabolism—PTEN—uterine cancer	3.99e-06	4.93e-05	CbGpPWpGaD
Mycophenolate mofetil—CYP3A4—Metabolism—MTHFR—uterine cancer	3.87e-06	4.78e-05	CbGpPWpGaD
Mycophenolate mofetil—CYP2C8—Metabolism—EP300—uterine cancer	3.83e-06	4.73e-05	CbGpPWpGaD
Mycophenolate mofetil—ALB—Metabolism—EP300—uterine cancer	3.8e-06	4.7e-05	CbGpPWpGaD
Mycophenolate mofetil—ABCG2—Metabolism—AKT1—uterine cancer	3.73e-06	4.6e-05	CbGpPWpGaD
Mycophenolate mofetil—ABCB1—Metabolism—PTEN—uterine cancer	3.5e-06	4.32e-05	CbGpPWpGaD
Mycophenolate mofetil—ABCB1—Metabolism—EP300—uterine cancer	3.33e-06	4.12e-05	CbGpPWpGaD
Mycophenolate mofetil—CYP3A5—Metabolism—PIK3CA—uterine cancer	3.27e-06	4.04e-05	CbGpPWpGaD
Mycophenolate mofetil—CYP2C8—Metabolism—PIK3CA—uterine cancer	2.83e-06	3.5e-05	CbGpPWpGaD
Mycophenolate mofetil—ALB—Metabolism—PIK3CA—uterine cancer	2.81e-06	3.48e-05	CbGpPWpGaD
Mycophenolate mofetil—CYP3A5—Metabolism—AKT1—uterine cancer	2.67e-06	3.3e-05	CbGpPWpGaD
Mycophenolate mofetil—ABCB1—Metabolism—PIK3CA—uterine cancer	2.47e-06	3.05e-05	CbGpPWpGaD
Mycophenolate mofetil—CYP2C8—Metabolism—AKT1—uterine cancer	2.31e-06	2.86e-05	CbGpPWpGaD
Mycophenolate mofetil—ALB—Metabolism—AKT1—uterine cancer	2.3e-06	2.84e-05	CbGpPWpGaD
Mycophenolate mofetil—CYP3A4—Metabolism—PTEN—uterine cancer	2.15e-06	2.66e-05	CbGpPWpGaD
Mycophenolate mofetil—CYP3A4—Metabolism—EP300—uterine cancer	2.05e-06	2.54e-05	CbGpPWpGaD
Mycophenolate mofetil—ABCB1—Metabolism—AKT1—uterine cancer	2.01e-06	2.49e-05	CbGpPWpGaD
Mycophenolate mofetil—CYP3A4—Metabolism—PIK3CA—uterine cancer	1.52e-06	1.88e-05	CbGpPWpGaD
Mycophenolate mofetil—CYP3A4—Metabolism—AKT1—uterine cancer	1.24e-06	1.53e-05	CbGpPWpGaD
